Longevity Health Holdings, Inc. (XAGE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Longevity Health Holdings, Inc. (XAGE) has a cash flow conversion efficiency ratio of 0.052x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-306.37K) by net assets ($-5.87 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Longevity Health Holdings, Inc. liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Longevity Health Holdings, Inc. - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Longevity Health Holdings, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Longevity Health Holdings, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Longevity Health Holdings, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
STMicroelectronics NV
LSE:0INB
|
0.221x |
|
Premier Miton Group plc
LSE:PMI
|
0.045x |
|
First Tin PLC
LSE:1SN
|
-0.028x |
|
Crystal Amber Fund Limited
LSE:CRS
|
-0.003x |
|
Mongolia Growth Group Ltd.
V:YAK-H
|
-0.015x |
|
XXL Energy Corp
V:XL
|
-0.009x |
|
T-Bull S.A
WAR:TBL
|
-0.195x |
|
Lucky Minerals Inc
V:LKY
|
0.001x |
Annual Cash Flow Conversion Efficiency for Longevity Health Holdings, Inc. (2021–2025)
The table below shows the annual cash flow conversion efficiency of Longevity Health Holdings, Inc. from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see XAGE market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-5.87 Million | $-3.33 Million | 0.567x | -39.07% |
| 2024-12-31 | $-4.71 Million | $-4.39 Million | 0.931x | +376.10% |
| 2023-12-31 | $24.75 Million | $-8.35 Million | -0.337x | -434.49% |
| 2022-12-31 | $-37.79 Million | $-3.81 Million | 0.101x | +153.45% |
| 2021-12-31 | $-29.58 Million | $-1.18 Million | 0.040x | -- |
About Longevity Health Holdings, Inc.
Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth fa… Read more